• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Tuesday's After-Market Session

    2/21/23 4:31:10 PM ET
    $AQB
    $BKD
    $EFTR
    $GLYC
    Meat/Poultry/Fish
    Consumer Staples
    Hospital/Nursing Management
    Health Care
    Get the next $AQB alert in real time by email

    Gainers

    • 1Life Healthcare (NASDAQ:ONEM) stock increased by 8.7% to $17.9 during Tuesday's after-market session. Trading volume for this security closed at 2.5 million, accounting for 100.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.6 billion.
    • Tivic Health Systems (NASDAQ:TIVC) shares rose 7.84% to $0.21. The company's market cap stands at $6.2 million.
    • Brookdale Senior Living (NYSE:BKD) stock increased by 6.95% to $3.23. The company's market cap stands at $603.3 million. As per the news, the Q4 earnings report came out today.
    • Prenetics Global (NASDAQ:PRE) shares increased by 5.0% to $1.05. The company's market cap stands at $124.7 million.
    • AquaBounty Technologies (NASDAQ:AQB) stock moved upwards by 4.99% to $0.85. The market value of their outstanding shares is at $60.4 million.
    • Harpoon Therapeutics (NASDAQ:HARP) shares rose 4.99% to $0.87. The market value of their outstanding shares is at $29.0 million.

    Losers

    • Procaps Gr (NASDAQ:PROC) stock declined by 13.4% to $3.94 during Tuesday's after-market session. The company's market cap stands at $444.5 million.
    • LianBio (NASDAQ:LIAN) stock fell 8.86% to $1.85. The company's market cap stands at $200.9 million.
    • GlycoMimetics (NASDAQ:GLYC) stock decreased by 7.3% to $1.78. This security traded at a volume of 81.8K shares come close, making up 5.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $93.3 million.
    • Minerva Surgical (NASDAQ:UTRS) shares decreased by 6.86% to $0.4. The company's market cap stands at $71.0 million.
    • Staar Surgical (NASDAQ:STAA) stock decreased by 6.86% to $62.9. The company's market cap stands at $3.0 billion. As per the press release, Q4 earnings came out today.
    • eFFECTOR Therapeutics (NASDAQ:EFTR) stock decreased by 6.57% to $0.47. Today's trading volume for this security ended up closing at 250.3K shares, which is 81.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $19.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AQB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AQB
    $BKD
    $EFTR
    $GLYC

    CompanyDatePrice TargetRatingAnalyst
    Prenetics Global Limited
    $PRE
    3/16/2026$29.00Buy
    Lake Street
    Prenetics Global Limited
    $PRE
    2/11/2026$36.00Buy
    Roth Capital
    STAAR Surgical Company
    $STAA
    2/3/2026$26.00Neutral
    Wedbush
    STAAR Surgical Company
    $STAA
    1/16/2026$13.00Underweight
    Morgan Stanley
    Brookdale Senior Living Inc.
    $BKD
    1/6/2026$13.00Underperform → Buy
    BofA Securities
    Brookdale Senior Living Inc.
    $BKD
    11/10/2025$14.00Equal Weight → Overweight
    Barclays
    STAAR Surgical Company
    $STAA
    4/21/2025$17.00Equal Weight
    Wells Fargo
    Brookdale Senior Living Inc.
    $BKD
    4/1/2025$7.00Equal Weight
    Barclays
    More analyst ratings

    $AQB
    $BKD
    $EFTR
    $GLYC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Prenetics Group Ltd. with a new price target

    Lake Street initiated coverage of Prenetics Group Ltd. with a rating of Buy and set a new price target of $29.00

    3/16/26 8:45:09 AM ET
    $PRE
    Blank Checks
    Finance

    Roth Capital initiated coverage on Prenetics Group Ltd. with a new price target

    Roth Capital initiated coverage of Prenetics Group Ltd. with a rating of Buy and set a new price target of $36.00

    2/11/26 7:52:37 AM ET
    $PRE
    Blank Checks
    Finance

    Wedbush initiated coverage on STAAR Surgical with a new price target

    Wedbush initiated coverage of STAAR Surgical with a rating of Neutral and set a new price target of $26.00

    2/3/26 8:08:13 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $AQB
    $BKD
    $EFTR
    $GLYC
    SEC Filings

    View All

    SEC Form 10-K filed by Tivic Health Systems Inc.

    10-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    3/30/26 5:34:51 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by STAAR Surgical Company

    SCHEDULE 13G/A - STAAR SURGICAL CO (0000718937) (Subject)

    3/27/26 1:17:37 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Brookdale Senior Living Inc.

    SCHEDULE 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

    3/26/26 4:44:58 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $AQB
    $BKD
    $EFTR
    $GLYC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Shah Darshan Ravindra

    3 - Prenetics Global Ltd (0001876431) (Issuer)

    3/30/26 6:36:02 AM ET
    $PRE
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Yeung Danny Sheng Wu

    3 - Prenetics Global Ltd (0001876431) (Issuer)

    3/30/26 6:31:10 AM ET
    $PRE
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Cheng Yin Pan

    3 - Prenetics Global Ltd (0001876431) (Issuer)

    3/24/26 10:30:07 AM ET
    $PRE
    Blank Checks
    Finance

    $AQB
    $BKD
    $EFTR
    $GLYC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

    IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.IM8's Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower's recommended foundational daily supplements in members' personalized health protocols. NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium heal

    3/24/26 11:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    Prenetics to Participate in the 38th Annual ROTH Conference

    NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA. Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throughout the conference. Management will also participate in a fireside chat at 8:30 a.m. PT and a Consumer Influencer panel discussion at 12:00 p.m. PT on Monday, March 23rd — both available via webc

    3/18/26 8:30:00 AM ET
    $PRE
    Blank Checks
    Finance

    Brookdale Reports February 2026 Occupancy

    BRENTWOOD, Tenn., March 9, 2026 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) reported today its occupancy for February 2026. February 2026 Occupancy ObservationsFebruary consolidated occupancy results:February 2026 weighted average occupancy increased 280 basis points year-over-year to 82.1%.Sequential weighted average occupancy seasonally declined 20 bps, reflecting the normal seasonal trend and in line with historical monthly trends for February.2026 first quarter-to-date weighted average occupancy of 82.2% represents a sequential occupancy change from the full 2025

    3/9/26 7:00:00 AM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $AQB
    $BKD
    $EFTR
    $GLYC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Broadwood Partners, L.P. bought $12,266,545 worth of shares (670,213 units at $18.30) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    3/13/26 7:59:59 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Large owner Broadwood Partners, L.P. bought $606,138 worth of shares (27,485 units at $22.05) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/13/26 9:30:12 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Large owner Broadwood Partners, L.P. bought $8,817,664 worth of shares (406,653 units at $21.68) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/8/26 7:31:31 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $AQB
    $BKD
    $EFTR
    $GLYC
    Leadership Updates

    Live Leadership Updates

    View All

    Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

    Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand's mission and products.IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US$100 million in Annual Recurring Revenue in just 11 months from launch.Bearman's rapid rise – including a historic points-scoring Ferrari debut at just 18—cements his reputation as one of motorsport's brightest young talents. NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading

    2/13/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

    Search Committee Has Initiated a Global Search to Select Next CEO STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors (the "Board") has appointed Warren Foust, President and Chief Operating Officer, and Deborah Andrews, Chief Financial Officer, as interim co-Chief Executive Officers, effective February 1, 2026. Mr. Foust and Ms. Andrews will work together with the other members of the executive leadership team, with support and guidance from the Board, as they lead the Company and manage its day-to-day operations.

    2/2/26 7:00:00 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

    Neal Bradsher and Richard LeBuhn of Broadwood and Christopher Wang of Yunqi Capital have Joined STAAR Board STAAR Chair Elizabeth Yeu and CEO Stephen Farrell have Stepped Down from the Board Farrell will Remain CEO until January 31, 2026 STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners, L.P. and its affiliates ("Broadwood"), which together own 31% of STAAR's outstanding common stock, today announced that Neal C. Bradsher and Richard T. LeBuhn of Broadwood and Christopher Wang of Yunqi Capital, which with its affiliates owns 6.5%

    1/15/26 8:30:00 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $AQB
    $BKD
    $EFTR
    $GLYC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Procaps Group S.A.

    SC 13D/A - Procaps Group, S.A. (0001863362) (Subject)

    12/3/24 7:20:10 PM ET
    $PROC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

    SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

    11/14/24 4:43:24 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care

    $AQB
    $BKD
    $EFTR
    $GLYC
    Financials

    Live finance-specific insights

    View All

    STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results

    Confident in China Progress and Future Roadmap A Clear Path Toward Sustainable Profitability and Growth Board and Leadership Transitions Support Strategy Execution and Shareholder Value Creation STAAR Interim co-CEOs Issue Letter to Shareholders Earnings Call and Webcast Today at 5:30 PM Eastern STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal year ended January 2, 2026. STAAR's Interim co-CEOs will be issuing a Letter to Shareholders after this earnings release, which can be found here: https://investors.staar.com/new

    3/3/26 4:01:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the fourth quarter and fiscal year ended January 2, 2026, on Tuesday, March 3 after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and business progress. Event: STAAR Surgical Fourth Quarter and Fiscal Year 2025 Financial Results Webcast Date: Tuesday, March 3, 2026 Time: 5:30 p.m. ET/ 2:30 p.m. PT Location: https://event.choruscall.com/mediaframe/webcast.html?webcastid=J3bNAuVd Topics on the c

    2/23/26 4:01:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

    Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero DebtCompany to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenetics.com NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium he

    2/18/26 9:11:26 AM ET
    $PRE
    Blank Checks
    Finance

    $AQB
    $BKD
    $EFTR
    $GLYC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care